He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
The positive benefit-risk profile of vericiguat in its approved indication in patients with HFrEF following a recent heart failure event based on the pivotal Phase III VICTORIA trial remains unchanged
LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Subscribe To Our Newsletter & Stay Updated
